Showing results (181-190 of 261) with videos related to
Sort By:
Pageof 27
BMC Medicine|December 19, 2024
The association of HDL-cholesterol levels with incident major adverse cardiovascular events and mortality in 0.6 million individuals with type 2 diabetes: a population-based retrospective cohort studyDavid Tak Wai Lui, Lanlan Li, Xiaodong Liu, et al.The Journal of Clinical Endocrinology and Metabolism|December 1, 2022
Effect of Inactivated and mRNA COVID-19 Vaccination on Thyroid Function Among Patients Treated for HyperthyroidismChun Ho Wong, Eunice Ka Hong Leung, Lawrence Chi Kin Tang, et al.Nature Communications|July 1, 2018
2D transition metal dichalcogenides with glucan multivalency for antibody-free pathogen recognitionTae Woog Kang, Juhee Han, Sin Lee, et al.Small (Weinheim an Der Bergstrasse, Germany)|March 24, 2018
Adjustable Intermolecular Interactions Allowing 2D Transition Metal Dichalcogenides with Prolonged Scavenging Activity for Reactive Oxygen SpeciesDaBin Yim, Ji Eun Kim, Hye-In Kim, et al.Scientific Reports|July 2, 2025
Serum Tsukushi level is negatively associated with cholesterol efflux capacity in metabolic dysfunction-associated steatotic liver disease: a cross-sectional studySum Lam, David T W Lui, Carol H Y Fong, et al.JAMA Network Open|May 19, 2023
Analysis of All-Cause Hospitalization and Death Among Nonhospitalized Patients With Type 2 Diabetes and SARS-CoV-2 Infection Treated With Molnupiravir or Nirmatrelvir-Ritonavir During the Omicron Wave in Hong KongDavid T W Lui, Matthew S H Chung, Eric H Y Lau, et al.Journal of Cellular and Molecular Medicine|November 19, 2016
Tannic acid inhibits EGFR/STAT1/3 and enhances p38/STAT1 signalling axis in breast cancer cellsPramod Darvin, Youn Hee Joung, Dong Young Kang, et al.European Journal of Endocrinology|November 10, 2021
PM20D1 is a circulating biomarker closely associated with obesity, insulin resistance and metabolic syndromeRanyao Yang, Yue Hu, Chi Ho Lee, et al.Alimentary Pharmacology & Therapeutics|September 10, 2024
Glycaemic control is a modifiable risk factor for hepatocellular carcinoma and liver-related mortality in patients with diabetesXianhua Mao, Ka-Shing Cheung, Jing-Tong Tan, et al.Gut|April 3, 2024
Optimal glycaemic control and the reduced risk of colorectal adenoma and cancer in patients with diabetes: a population-based cohort studyXianhua Mao, Ka Shing Cheung, Jing-Tong Tan, et al.Pageof 27